Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06236243Not ApplicableCompleted

Effect of Korean Red Ginseng Extract on Blood Flow in Healthy Adults

Role: lead

NCT03272295Not ApplicableCompleted

A Nicotine Pharmacokinetics and Smoking Behaviour Study Examining Cigarette Ingredients

Role: collaborator

NCT02796664Not ApplicableCompleted

Preventive Effects of Ginseng Against Atherosclerosis

Role: collaborator

NCT02428998Not ApplicableCompleted

Safety for 24 Weeks Intake of Korean Red Ginseng in Adults

Role: lead

NCT02039635Not ApplicableCompleted

Korean Red Ginseng in Treating Patients With Fatigue Caused by Chemotherapy for Colorectal Cancer

Role: lead

All 5 trials loaded